FDA Clears

Related by string. * fda . FDAs . Fda : Drug Administration FDA . Receives FDA Clearance . reformulates existing FDA . FDA Orphan Drug . FDA Clearance . FDA MedWatch Adverse Event . FDA Approves / cleared . clears . clearer . clearing . Clearing . Cleared . clear : Clear Channel Communications . Clear Channel Radio . Clear Lake . Clear Channel Outdoor . Clear Creek . Clear Channel . clearer picture * *

Related by context. Frequent words. (Click for all words.) 89 Receives FDA Clearance 84 FDA Approves 83 Completes Enrollment 81 Drug Candidate 81 FDA Clearance 81 Shows Promise 78 Awarded Patent 78 Receives Patent 78 Announces Initiation 77 Study Demonstrates 77 FDA Warns 77 Clinical Trial Results 77 Introduces Next Generation 76 k Clearance 76 Protects Against 76 Increases Risk 75 Cholesterol Drug 75 Files Patent 75 Phase III Trial 75 Begins Shipping 75 Receives Positive 74 Phase III Clinical Trial 74 Announce Collaboration 74 Commercialize 74 FDA Approval 74 Reports Positive 74 Receives CE 74 Discontinues 73 Announces Publication 73 Patients Treated 73 Study Indicates 73 Announces Positive 73 Inhibits 73 Provide Comprehensive 73 Study Confirms 73 Non Invasive 72 Launches Next Generation 72 Announces Successful Completion 72 Announces Presentation 72 Heart Failure Patients 72 Initiates Phase 72 Low Dose 72 Provides Guidance 72 Unveils Next Generation 71 Monoclonal Antibody 71 Pivotal Phase III 71 Introduces Innovative 71 Q4 Loss Narrows 71 Q3 Loss Narrows 71 Bird Flu Vaccine 71 Q3 Loss Widens 71 Receives Approval 71 Announces Issuance 71 Breast Cancer Treatment 71 Combination Therapy 71 Researchers Identify 71 Pivotal Phase 71 Announces Availability 71 Enters Agreement 71 Successfully Completes 71 Elderly Patients 71 Chronic Hepatitis C 70 Q2 Loss Narrows 70 Breast Cancer Patients 70 Acquire Assets 70 Fully Automated 70 Q2 Loss Widens 70 Q1 Loss Widens 70 Induces 70 Study Identifies 70 Researchers Develop 70 Outperforms 70 Gets Approval 70 Pivotal Trial 70 Reduce Risk 70 Net Loss Narrows 69 Updates Guidance 69 Bullish Engulfing Pattern 69 Strengthens Its 69 Q4 Loss Widens 69 Jointly Develop 69 Completes Successful 69 Cervical Cancer Vaccine 69 Announce Agreement 69 Attains 69 Launches Innovative 69 Small Molecule 69 Postmenopausal Women 69 Cancer Cells 69 Hormone Therapy 69 Extends Tender Offer 69 Extends Leadership 69 Revolutionizes 69 Lowers Guidance 69 Increased Risk 69 Forecast Quick Facts 69 Announces Definitive Agreement 69 Acquires Assets 68 Int J 68 Launches Enhanced 68 Long Lasting

Back to home page